Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
Hashimoto S, Kroes JA, Eger KA, Mau Asam PF, Hofstee HB, Bendien SA, Braunstahl GJ, Broeders MEAC, Imming LM, Langeveld B, Maitland-van der Zee AH, Oud KTM, Patberg KW, Smeenk FWJM, Romme EAPM, van Bezouw MJ, van de Ven MJ, van Veen A, van Velzen E, van Veen IHPAA, Weersink EJM, Ten Brinke A, Sont JK, Bel EH; RAPSODI team.
Hashimoto S, et al. Among authors: kroes ja.
J Allergy Clin Immunol Pract. 2022 Aug;10(8):2099-2108.e6. doi: 10.1016/j.jaip.2022.04.014. Epub 2022 Apr 26.
J Allergy Clin Immunol Pract. 2022.
PMID: 35487369
Free article.